Baxdela 300 mg Injection
RxNorm 1927672
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1927672 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Baxdela 300 mg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Baxdela 300 mg (as delafloxacin meglumine 433 mg) Injection
(Atom ID: 9197725)
PSNPrescribable
Prescribable Name (PSN):
Baxdela 300 mg Injection
(Atom ID: 9197703)
SYPrescribable
Synonym (SY):
Baxdela 300 mg Injection
(Atom ID: 9197704)
SBDPrescribable
Semantic Branded Drug (SBD):
Delafloxacin 300 mg Injection [Baxdela]
(Atom ID: 9197702)
Patient Education
Delafloxacin Injection
Delafloxacin injection is used treat skin infections and certain types of pneumonia (an infection of the lungs) caused by bacteria in adults. Delafloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infections.
[Learn More]
* Please review the disclaimer below.